Gennex Laboratories Ltd — Quarterly Results & Earnings

₹7.13

-11.88%

Profit Growth YoY4.14%Latest quarter

Sales Growth YoY11.56%Latest quarter

Sales CAGR 5Y19.94%5 year compound

Profit CAGR 5Y59.30%5 year compound

📋

Quarterly Performance

YoY Profit Growth+4.14%

📈 Moderate growth

YoY Sales Growth+11.56%

✅ Strong growth

OPM 5Y Average

Operating profit margin

12.25%

EPS Growth 5Y

53.64%

Interest Coverage

Higher = safer debt servicing

6.40

ROE

10.23%

ROCE

13.01%

💡

Growth Analysis

Gennex Laboratories Ltd reported YoY profit growth of 4.14% and revenue growth of 11.56% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 19.94% and profits at 59.30% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Gennex Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.